you are here: Home News Astrazeneca Pharma India

Astrazeneca Pharma India

Stocks to Watch Today: Premier Energies, Capri Global, Protean eGov Tech, ITD Cementation, Jana Small Finance Bank, IRB Infra, Nibe in focus on 10 June
Stocks to Watch Today: Tata Motors, M&M, Niva Bupa, Alembic Pharma, IRCON, Godrej Properties, Titagarh, AstraZeneca, Genus Power, Nykaa in focus on 2 June
AstraZeneca Pharma shares extend fall on fifth day; gets approval for cancer drug
AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi
AstraZeneca Pharma shares jump 12% to 52-week high on CDSCO permission
Gainers and Losers: 10 stocks that moved the most on March 27
AstraZeneca India falls 0.6% despite a new CFO and nod to drug imports
AstraZeneca Pharma shares gain 3% on CDSCO approval for sale of Tremelimumab
AstraZeneca Pharma gets CDSCO nod to import Enhertu for breast cancer treatment
AstraZeneca India MD Gagandeep Singh Bedi resigns from post effective December 31
AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 crore
AstraZeneca Pharma India Q4 net profit up nearly 3-fold to Rs 27.27 crore
AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore
AstraZeneca Pharma India Q2 net profit up 83% at Rs 26 crore
AstraZeneca Pharma India Q1 net profit declines 13% at Rs 18.63 crore
AstraZeneca's Dapagliflozin gets DCGI nod for treatment of heart failure patients
AstraZeneca Pharma India Q3 net profit down 8% to Rs 27cr
AstraZeneca Pharma India Q4 net profit jumps threefold to Rs 9.82 cr
AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 cr
AstraZeneca gets marketing permission for cancer drug in India
AstraZeneca Pharma India posts Q1 net profit of Rs 2.71 cr
AstraZeneca to receive up to $26.5m grant from promoter
AstraZeneca Pharma quotes ex-dividend

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Astrazeneca Pharma India

Stocks to Watch Today: Premier Energies, Capri Global, Protean eGov Tech, ITD Cementation, Jana Small Finance Bank, IRB Infra, Nibe in focus on 10 June

Stocks to Watch Today: Tata Motors, M&M, Niva Bupa, Alembic Pharma, IRCON, Godrej Properties, Titagarh, AstraZeneca, Genus Power, Nykaa in focus on 2 June

AstraZeneca Pharma shares extend fall on fifth day; gets approval for cancer drug

AstraZeneca Pharma shares gain 3% on CDSCO nod for expanded use of cancer drug Imfinzi

AstraZeneca Pharma shares jump 12% to 52-week high on CDSCO permission

Gainers and Losers: 10 stocks that moved the most on March 27

AstraZeneca India falls 0.6% despite a new CFO and nod to drug imports

AstraZeneca Pharma shares gain 3% on CDSCO approval for sale of Tremelimumab

AstraZeneca Pharma gets CDSCO nod to import Enhertu for breast cancer treatment

AstraZeneca India MD Gagandeep Singh Bedi resigns from post effective December 31

AstraZeneca Pharma India Q1 net profit declines 45% to Rs 10.24 crore

AstraZeneca Pharma India Q4 net profit up nearly 3-fold to Rs 27.27 crore

AstraZeneca Pharma India Q3 net profit declines 21% at Rs 21 crore

AstraZeneca Pharma India Q2 net profit up 83% at Rs 26 crore

AstraZeneca Pharma India Q1 net profit declines 13% at Rs 18.63 crore

AstraZeneca's Dapagliflozin gets DCGI nod for treatment of heart failure patients

AstraZeneca Pharma India Q3 net profit down 8% to Rs 27cr

AstraZeneca Pharma India Q4 net profit jumps threefold to Rs 9.82 cr

AstraZeneca Pharma India Q2 net profit dips 67% to Rs 9.13 cr

AstraZeneca gets marketing permission for cancer drug in India

AstraZeneca Pharma India posts Q1 net profit of Rs 2.71 cr

AstraZeneca to receive up to $26.5m grant from promoter

AstraZeneca Pharma quotes ex-dividend